ArticleFrontiers in oncology2022

Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.

Andrew Ip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.